Vitreous injection of anti vascular endothelium growth factor for macular edema.

Vitreous injection of anti vascular endothelium growth factor for macular edema. - VEGF injection for macular edema

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012094

Enrollment

100

Registered

2013-10-30

Start date

2013-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

macular edema

Interventions

Anti-VEGF addiministration using TER method. Anti-VEGF addiministration using PRN method.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Macular edema with diabetes, retinal vein occulusion and uveites, those who obtained informed concent.

Exclusion criteria

Exclusion criteria: Those who under 20 years old, determined that not appropriatable by doctor and pregnant women.

Design outcomes

Primary

Measure	Time frame
Visual acuity, intraocular pressure, anterior&posterior eye examination, visual function and morphology of retina.	—

Countries

Japan

Contacts

Public ContactMasahiko Sugimoto

Mie University Schoolof Medicine Department of Ophthalmology

sugmochi@clin.medic.mie-u.ac.jp059-232-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026